Enterome
Latest round
- Series E
Last raised
- Oct 2020
Total raised
- $67M
Investors
- 8
About Enterome
Founded in 2011 and headquartered in Paris, France, Enterome SA specializes in immunotherapy for cancer treatment.Enterome is engaged in developing innovative immunotherapy treatments targeting various cancer types, including glioblastoma, adrenal tumors, non-Hodgkin lymphoma, and colorectal cancer. Their OncoMimics™ platform leverages patient effector memory T cells to generate robust immune responses against tumors.80. The company aims to expand its market presence in Europe and North America, with specific plans to introduce new immunotherapy products designed to enhance treatment efficacy.
Who invested in Enterome
8 investors across 3 rounds
See all investors in Enterome
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Enterome
Who invested in Enterome?
Enterome has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enterome raised?
Enterome has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Enterome last raise money?
Enterome's most recent round on record is a Series E, in Oct 2020.
What does Enterome do?
Founded in 2011 and headquartered in Paris, France, Enterome SA specializes in immunotherapy for cancer treatment.
Where is Enterome headquartered?
Enterome is headquartered in Paris, France.
Which VCs invest in companies like Enterome?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Enterome's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Enterome? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.